Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Red~Oneon Oct 16, 2021 10:22pm
211 Views
Post# 34014374

RE:Whew

RE:WhewOkay since you asked : " I wonder if they will have a halt before they start ...wouldn"t that make it much more exciting .... can't wait ... how about you" 

I think that any news release, including one with a Halt will result in a further drop in shareprice. You and your pals from the Insider sites think they can pump it up but the truth is all those promises earlier made by the company are already built-in to the current shareprice, it's called built-in expectations, so I sincerely hope this pops but most experienced traders know it won't. So for some of the honest bagholders out there I sincerely hope something drives this to at least $1.50 
and soon .

You and your pals however, are blinded by the fact because you are so heavily into this stock with no hope for at least a year you can't think straight, admit it, quit trying to suck people into your mistake .... N.O. will be front page news someday soon and I hope this stock can get a piece of that.  
The funny thing about it all is that based on the shareprice performance since the announcement of the split, well that tells the tale. It shows who is right and who is wrong.

Pumping or bashing this stock on a bullboard like this does not affect the shareprice. So get over it and be real for once. Good Luck
<< Previous
Bullboard Posts
Next >>